» Articles » PMID: 18262543

Disulfide Bond Introduction for General Stabilization of Immunoglobulin Heavy-chain Variable Domains

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2008 Feb 12
PMID 18262543
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Several antibody fragment engineering techniques aim at intrinsic stability enhancement, but are not applied in a truly generic way. Here, a strategy is proposed whereby consistent gain in stability is accomplished by introducing a specific disulfide bond between two opposite beta-strands in the hydrophobic core of the immunoglobulin heavy-chain variable domain of heavy-chain antibodies (Nanobody). Besides the rational design of a disulfide bond between residues 39 and 87, a Nanobody harboring an extra naturally occurring cystine between residues 54 and 78 was compared to an equivalent Nanobody without that cystine. Both novel disulfide cross-links were introduced in several Nanobodies in various combinations. Interestingly, only the extra naturally occurring cystine consistently increased the conformational and thermal stabilities of wild-type Nanobodies without affecting antigen binding.

Citing Articles

Experimental and Computational Studies on Domain-Swapped Structure Stabilization of an Antibody Light Chain by Disulfide Bond Introduction.

Fitriana W, Sakai T, Duan L, Hengphasatporn K, Shigeta Y, Mashima T J Med Chem. 2024; 67(24):22313-22321.

PMID: 39656517 PMC: 11684012. DOI: 10.1021/acs.jmedchem.4c02570.


Enhancing the sensitivity of immunomagnetic assay for 3-phenoxybenzonic acid: a novel approach utilizing magnetosome-nanobody complexes and gold nanoparticles probes.

He J, Wang Y, Zhao L, Chen X, Tang F, Gu S Mikrochim Acta. 2024; 191(10):635.

PMID: 39347992 DOI: 10.1007/s00604-024-06725-2.


TEMPRO: nanobody melting temperature estimation model using protein embeddings.

Alvarez J, Dean S Sci Rep. 2024; 14(1):19074.

PMID: 39154093 PMC: 11330463. DOI: 10.1038/s41598-024-70101-6.


Single-domain antibodies as therapeutics for solid tumor treatment.

Wang M, Ying T, Wu Y Acta Pharm Sin B. 2024; 14(7):2854-2868.

PMID: 39027249 PMC: 11252471. DOI: 10.1016/j.apsb.2024.03.016.


Precise isolation and structural origin of an ultra-specific nanobody against chemical compound.

Yang H, Vasylieva N, Wang J, Li Z, Duan W, Chen S J Hazard Mater. 2023; 458:131958.

PMID: 37429192 PMC: 10686526. DOI: 10.1016/j.jhazmat.2023.131958.